IL15 and cancer: TriKEs are composed of three separate binding regions including a single domain antibody (VHH) that binds CD16, an scFv that binds a tumor antigen present on cancer cells, and cross-linked wildtype human IL-15 that mediates cytokine signaling on the NK cells.